Results 211 to 220 of about 1,489,579 (226)

In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates

International Journal of Antimicrobial Agents, 2021
Spyros Pournaras, Joseph Meletiadis, Paschalis Paranos   +2 more
exaly  

Evolutionary Trajectories toward High-Level β-Lactam/β-Lactamase Inhibitor Resistance in the Presence of Multiple β-Lactamases

Antimicrobial Agents and Chemotherapy, 2022
Linus Sandegren, Fredrika Rajer, Philip A Karlsson   +2 more
exaly  

QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics

Frontiers in Microbiology, 2021
Maxim Totrov, Olga Lomovskaya, Scott Hecker   +2 more
exaly  

β-Lactam/β-Lactamase Inhibitor Combinations

Annals of Pharmacotherapy, 2015

exaly  

Resistance to Novel β-Lactam–β-Lactamase Inhibitor Combinations

Infectious Disease Clinics of North America, 2020
Andrew Mack, Robert Bonomo, Krisztina Papp-Wallace   +2 more
exaly  

An update on β-lactamase inhibitor discovery and development

Drug Resistance Updates, 2018
Jean-Denis Docquier, Stefano Mangani
exaly  

Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®

Bioorganic and Medicinal Chemistry Letters, 2014
Helen Chen, Katherine Young, Jun Lu
exaly  

The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections

Expert Opinion on Pharmacotherapy, 2019
Krisztina Papp-Wallace
exaly  

Structural analysis of the CARB β-lactamase from Vibrio parahaemolyticus facilitates application of the β-lactam/β-lactamase inhibitor therapy

Biochimie, 2020
Changshui Liu, Peihai Li
exaly  

Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination

Expert Review of Anti-Infective Therapy, 2007
James Karlowsky, Ethan Rubinstein
exaly